Table 1.

Patients’ characteristics

No.	Diagnosis	Age at cryopreservation	AMH prior to surgery (μg/l)	Chemotherapy prior to surgery (Y/N)
1	Morbus Hodgkin	26	1.06	N
2	Breast Cancer	33	2.66	N
3	Morbus Hodgkin	22	Not applicablea	N
4	Breast cancer	33	0.86	N
5	Breast cancer	27	2.14	N
6	Morbus Hodgkin	27	1.62	Y
7	Breast Cancer	39	<0.17	N
8	ALL	20	2.66	Y
9	B-NHL	22	0.33	Y
10	AML	23	<0.17	Y
11	NHL	25	2.70	N

In 10 out of 11 patients, AMH levels were measured before the laparoscopical retrieval of ovarian tissue for cryopreservation. Seven patients did not receive chemotherapy before ovarian tissue cryopreservation and four patients received chemotherapy before ovarian tissue cryopreservation. In one patient^a, AMH level (<0.17 μg/l) was determined after the surgery and after the first cycle of chemotherapy